Lipid metabolism reprogramming in endometrial cancer: biologic underpinnings, prognostic implications, and therapeutic opportunities
Abstract Endometrial cancer is strongly associated with obesity and other metabolic disorders, but host-level associations do not necessarily imply that tumor cells depend on a specific lipid pathway. This review therefore considers two related questions: how obesity, insulin resistance, and dyslipidemia influence endo...